España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Astria Therapeutics
ATXS
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$9.61
0.27
2.89%
Pre-Market: 7:00 AM EDT
Get Report
Comment
Astria Therapeutics (ATXS) Forecast
News
Earnings
Astria Therapeutics (ATXS) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Astria Therapeutics (NASDAQ:ATXS) Stock
Astria Therapeutics Stock (NASDAQ: ATXS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, November 14, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Astria ...
Benzinga Newsdesk
Oppenheimer Maintains Outperform on Astria Th...
Benzinga Newsdesk
Wednesday, November 13, 2024
Astria Therapeutics Q3 EPS $(0.42) Misses $(0...
Benzinga Newsdesk
Wednesday, October 16, 2024
European Commission Grants Orphan Medicinal P...
Benzinga Newsdesk
Monday, September 30, 2024
Astria Therapeutics Receives FDA Orphan Drug ...
Benzinga Newsdesk
Friday, September 27, 2024
HC Wainwright & Co. Reiterates Buy on Astria ...
Benzinga Newsdesk
Thursday, September 19, 2024
Astria Therapeutics To Present Initial Naveni...
Benzinga Newsdesk
Tuesday, August 13, 2024
Astria Therapeutics shares are trading higher...
Benzinga Newsdesk
Wedbush Reiterates Outperform on Astria Thera...
Benzinga Newsdesk
Oppenheimer Maintains Outperform on Astria Th...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Astria ...
Benzinga Newsdesk
Monday, August 12, 2024
Astria Therapeutics Q2 2024 Adj EPS $(0.43) M...
Benzinga Newsdesk
Monday, July 29, 2024
TD Cowen Initiates Coverage On Astria Therape...
Benzinga Newsdesk
Tuesday, May 21, 2024
Oppenheimer Maintains Outperform on Astria Th...
Benzinga Newsdesk
Friday, May 10, 2024
HC Wainwright & Co. Reiterates Buy on Astria ...
Benzinga Newsdesk
Wedbush Reiterates Outperform on Astria Thera...
Benzinga Newsdesk
Thursday, May 09, 2024
Astria Therapeutics Q1 2024 GAAP EPS $(0.38),...
Benzinga Newsdesk
Tuesday, April 23, 2024
HC Wainwright & Co. Maintains Buy on Astria T...
Benzinga Newsdesk
Tuesday, March 26, 2024
Wedbush Maintains Outperform on Astria Therap...
Benzinga Newsdesk
Monday, March 25, 2024
HC Wainwright & Co. Maintains Buy on Astria T...
Benzinga Newsdesk
Astria Therapeutics shares are trading higher...
Benzinga Newsdesk
Astria Therapeutics Announces Initial Proof-o...
Benzinga Newsdesk
Wednesday, March 20, 2024
Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
Thursday, March 14, 2024
HC Wainwright & Co. Reiterates Buy on Astria ...
Benzinga Newsdesk
Tuesday, March 05, 2024
Wedbush Reiterates Outperform on Astria Thera...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Astria ...
Benzinga Newsdesk
Monday, March 04, 2024
Astria Therapeutics Q4 EPS $(0.86) Down From $(0.72) YoY
Happy Mohamed
Tuesday, January 30, 2024
Wedbush Reiterates Outperform on Astria Thera...
Benzinga Newsdesk
Astria Therapeutics Announces Pricing Of $125...
Benzinga Newsdesk
Thursday, January 25, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Tuesday, January 16, 2024
Astria Therapeutics 13G Filing Shows TCG Cros...
Benzinga Newsdesk
Tuesday, December 26, 2023
$5.6M Bet On This Real Estate Stock? Check Out These 3 Stocks Insiders Are Buying
Avi Kapoor
Wednesday, November 15, 2023
Oppenheimer Maintains Outperform on Astria Th...
Benzinga Newsdesk
Monday, November 13, 2023
Astria Therapeutics Q3 EPS $(0.63) Vs $(0.87)...
Benzinga Newsdesk
Earnings Scheduled For November 13, 2023
Benzinga Insights
Friday, November 10, 2023
Earnings Preview For Astria Therapeutics
Benzinga Insights
Astria Therapeutics Presents New Phase 1a Dat...
Benzinga Newsdesk
Friday, November 03, 2023
Astria Therapeutics To Present New STAR-0215 ...
Benzinga Newsdesk
Thursday, October 19, 2023
Astria Therapeutics Director Trades $7.00M In Company Stock
Benzinga Insights
Friday, October 13, 2023
Expert Ratings for Astria Therapeutics
Benzinga Insights
Wedbush Maintains Outperform on Astria Therap...
Benzinga Newsdesk
Thursday, October 12, 2023
HC Wainwright & Co. Maintains Buy Rating for Astria Therapeutics: Here's What You Need To Know
Benzinga Insights
Exxon Mobil To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Thursday
Lisa Levin
HC Wainwright & Co. Maintains Buy on Astria T...
Benzinga Newsdesk
Astria Therapeutics Prices $64M Underwritten ...
Benzinga Newsdesk
Wednesday, October 11, 2023
Astria Therapeutics Priced 8,253,895 Share Offering Of Its Common Stock And Accompanying Common Stock Warrants To Purchase An Aggregate Of 6,190,418 Shares Of Common Stock, @ $6.514
Charles Gross
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Astria Therapeutics Enters Worldwide Exclusiv...
Benzinga Newsdesk
Tuesday, October 10, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
